Broad antigenic coverage induced by vaccination with virus-based cDNA libraries cures established tumors
Related Experiment Video
Updated: May 31, 2026

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo
Published on: January 7, 2019
Timothy Kottke1, Fiona Errington, Jose Pulido
1Department of Molecular Medicine, Mayo Clinic, Rochester, Minnesota, USA.
Abstract:
Effective cancer immunotherapy requires the release of a broad spectrum of tumor antigens in the context of potent immune activation. We show here that a cDNA library of normal tissue, expressed from a highly immunogenic viral platform, cures established tumors of the same histological type from which the cDNA library was derived. Immune escape occurred with suboptimal vaccination, but tumor cells that escaped the immune pressure were readily treated by second-line virus-based immunotherapy. This approach has several major advantages. Use of the cDNA library leads to presentation of a broad repertoire of (undefined) tumor-associated antigens, which reduces emergence of treatment-resistant variants and also permits rational, combined-modality approaches in the clinic. Finally, the viral vectors can be delivered systemically, without the need for tumor targeting, and are amenable to clinical-grade production. Therefore, virus-expressed cDNA libraries represent a novel paradigm for cancer treatment addressing many of the key issues that have undermined the efficacy of immuno- and virotherapy to date.
Insights
A novel cancer immunotherapy using a cDNA library expressed from a viral platform effectively cures tumors. This approach presents diverse tumor antigens, reducing treatment resistance and offering a new paradigm for cancer therapy.
Area of Science:
- Oncology
- Immunology
- Virology
Background:
- Effective cancer immunotherapy necessitates broad tumor antigen release and robust immune activation.
- Existing immunotherapies face challenges with immune escape and treatment resistance.
Purpose of the Study:
- To investigate a novel cancer treatment strategy using a cDNA library expressed from a viral platform.
- To evaluate the efficacy of this approach in curing established tumors and overcoming immune escape.
Main Methods:
- A cDNA library derived from normal tissue was expressed using a highly immunogenic viral platform.
- The therapy was tested on established tumors of the same histological type as the cDNA source.
- Suboptimal vaccination and subsequent immune escape were assessed, followed by second-line immunotherapy.
Main Results:
- The virus-expressed cDNA library successfully cured established tumors.
- Immune escape was observed with suboptimal vaccination but was overcome by second-line immunotherapy.
- The approach presented a broad repertoire of tumor-associated antigens, minimizing treatment-resistant variants.
Conclusions:
- Virus-expressed cDNA libraries offer a novel paradigm for cancer treatment.
- This strategy addresses key limitations in current immunotherapies and virotherapies.
- The method allows for systemic delivery, broad antigen presentation, and potential for combination therapies.
More Related Videos
08:10Simultaneous Quantification of Anti-vector and Anti-transgene-Specific CD8+ T Cells Via MHC I Tetramer Staining After Vaccination with a Viral Vector
Published on: November 28, 2018
12:43Generation of a Novel Dendritic-cell Vaccine Using Melanoma and Squamous Cancer Stem Cells
Published on: January 6, 2014
Related Concept Videos
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Tumor Immunotherapy
Vaccinations
Vaccines
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
Targeted Cancer Therapies
There are several types of targeted therapies against specific...